TTR and cardiac amyloidosis: The most common pathogenic TTR mutations are Val22Ile and Val30Met.[6] The Val22Ile variant occurs in 8% of suspected cardiac amyloidosis in Black/African American patients, while the Val30Met variant is prevalent in Japan, Sweden, and Brazil.[7] In contrast, the number of patients with p.Leu75Pro variant is limited.